Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B.

BACKGROUND & AIMS Histologic analyses of liver fibrosis have been limited by small sample sizes and the predominance of samples from patients with active hepatitis. METHODS We performed a prospective study of transient elastography in treatment-naive patients with chronic hepatitis B, to investigate the relationship between hepatitis B virus (HBV) genotype and liver fibrosis. A validated liver stiffness measurement algorithm was used to define insignificant fibrosis and advanced fibrosis. RESULTS Of 1106 patients, 711 (64%) were older than age 40, 370 (34%) had positive test results for hepatitis B e antigen (HBeAg), and 386 (35%) had increased serum levels of alanine aminotransferase. Of the patients, 524 (49%) had genotype B and 582 (51%) had genotype C HBV infection. Patients with genotype C infection had insignificant fibrosis less often (42% vs 55%; P < .0001) and advanced fibrosis more often (25% vs 19%; P = .015) than those infected with genotype B HBV. The difference in the severity of liver fibrosis between the 2 HBV genotypes was most marked among patients older than age 40 and those who tested negative for HBeAg. The mean age of patients infected by genotype C was greater than that of patients infected by genotype B HBV (41 vs 36 y). Among patients who were older than age 40 and tested negative for HBeAg, those with genotype C infection had higher levels of HBV DNA and alanine aminotransferase than those with genotype B HBV. CONCLUSIONS Genotype C HBV was associated with more severe liver fibrosis than genotype B HBV, probably because of delayed HBeAg seroconversion and prolonged active disease.

[1]  Bryan Lau,et al.  Exceeding the limits of liver histology markers. , 2009, Journal of hepatology.

[2]  A. Bilalis,et al.  Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection? , 2008, Hepatology.

[3]  W. Yap,et al.  Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index , 2008, Alimentary pharmacology & therapeutics.

[4]  Chien-Jen Chen,et al.  Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.

[5]  Eddie Y. T. Ng,et al.  Phylogenetic, Virological, and Clinical Characteristics of Genotype C Hepatitis B Virus with TCC at Codon 15 of the Precore Region , 2006, Journal of Clinical Microbiology.

[6]  A. Chan,et al.  Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B , 2009, Journal of viral hepatitis.

[7]  A. Chim,et al.  A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg‐negative chronic hepatitis B in China , 2008, Journal of viral hepatitis.

[8]  S. Yuen,et al.  Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase , 2007, Hepatology.

[9]  V. Wong,et al.  High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Pierre Bedossa,et al.  Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[11]  Y. N. Park,et al.  Usefulness of FibroScan for Detection of Early Compensated Liver Cirrhosis in Chronic Hepatitis B , 2009, Digestive Diseases and Sciences.

[12]  F. Chan,et al.  Hepatitis B Virus Genotype C Takes a More Aggressive Disease Course Than Hepatitis B Virus Genotype B in Hepatitis B e Antigen-Positive Patients , 2003, Journal of Clinical Microbiology.

[13]  F. Chan,et al.  Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong , 2002, American Journal of Gastroenterology.

[14]  Ding‐Shinn Chen,et al.  Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. , 2000, Gastroenterology.

[15]  V. Wong,et al.  Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma , 2004, Gut.

[16]  V. Wong,et al.  A review of the natural history of chronic hepatitis B in the era of transient elastography , 2008, Antiviral therapy.

[17]  C. Chu,et al.  Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. , 2007, Gastroenterology.

[18]  H. Chan,et al.  Molecular virology in chronic hepatitis B: genotypes. , 2005, Hospital medicine.

[19]  J. Sung,et al.  Hepatocellular Carcinoma and Hepatitis B Virus , 2006, Seminars in liver disease.

[20]  Eva Herrmann,et al.  Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. , 2008, Gastroenterology.

[21]  Colin P West,et al.  Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  V. Wong,et al.  Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B , 2009, Journal of gastroenterology and hepatology.

[23]  A. Lok,et al.  Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. , 2002, Gastroenterology.

[24]  V. Wong,et al.  Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B , 2008, Gut.

[25]  F. Sugauchi,et al.  Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. , 2003, Gastroenterology.

[26]  M. Yuen,et al.  Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. , 2006, Journal of hepatology.

[27]  Hao Wang,et al.  Two-year Lamivudine treatment for Hepatitis B e Antigen-Negative Chronic Hepatitis B: A Double-Blind, Placebo-Controlled Trial , 2006, Antiviral therapy.

[28]  B. McMahon,et al.  Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. , 2007, Gastroenterology.

[29]  J. Sung,et al.  Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection. , 2002 .

[30]  Makoto Arai,et al.  Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease , 2003, Hepatology.

[31]  O. Chazouilleres,et al.  Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome. , 2007, Clinical Gastroenterology and Hepatology.

[32]  Vincent Wai-Sun Wong,et al.  Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  Kwong-Sak Leung,et al.  Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C. , 2005, The Journal of infectious diseases.

[34]  W. Lau,et al.  Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation , 2002, Journal of medical virology.